Insulin glargine, recombinant Subcutaneous and Seebri Neohaler
Determining the interaction of Insulin glargine, recombinant Subcutaneous and Seebri Neohaler and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: glycopyrrolate
Brand name: Lonhala Magnair Starter Kit, Seebri Neohaler, Cuvposa, GLYRX-PF, Robinul, Robinul Forte
Synonyms: Seebri Neohaler (inhalation)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine, recombinant Subcutaneous-Seebri Neohaler inhalation
- Insulin glargine, recombinant Subcutaneous-Segesterone Acetate and Ethinyl Estradiol
- Insulin glargine, recombinant Subcutaneous-Segesterone acetate and ethinyl estradiol Vaginal
- Insulin glargine, recombinant Subcutaneous-Segluromet
- Insulin glargine, recombinant Subcutaneous-Seizalam Injection
- Insulin glargine, recombinant Subcutaneous-Seldane
- Seebri Neohaler-Insulin glulisine
- Seebri Neohaler-Insulin Glulisine (Cartridges and Pens)
- Seebri Neohaler-Insulin Glulisine (Vials)
- Seebri Neohaler-Insulin glulisine Subcutaneous
- Seebri Neohaler-Insulin human inhaled Inhalation
- Seebri Neohaler-Insulin human regular Injection